¡°ÌìÈ»ÂÛ̳¡±µÚ24½²
»ã±¨±êÌ⣺ÃâÒßÁÆ·¨¿ÉÍûÖÎÓúÖ×Áö¡ª¡ª2018Äêŵ±´¶ûÉúÀíѧ»òҽѧ½±¼ò½é
»ã±¨ÈË£ºÀî±ó ×êÑÐÔ±£¨ÉϺ£ÊÐÃâÒßѧ×êÑÐËù£©
Ö÷³ÖÈË£ºÐ¤ºÃºº ½ÌÊÚ £¨Ð±¦GGÐÔÃü¿ÆÑ§Ñ§Ôº£©
¹¦·ò£º2018Äê11ÔÂ30ÈÕ£¨ÖÜÎ壩ÉÏÎç9: 30
µØÖ·£ºÐ£±¾²¿¶«ÇøÐÔÃü¿ÆÑ§Ñ§Ôº800ÊÒ
Ö÷°ì£ºÐ±¦GGÆÚ¿¯Éç¡¶ÌìÈ»ÔÓÖ¾¡·±à×벿
»ã±¨ÄÚÈÝ£º2018Äêŵ±´¶ûÉúÀíѧ»òҽѧ½±±»ÊÚÓèÁËÃÀ¹úÃâÒßѧ¼Òղķ˹¡¤°¬ÀûÉ£¨James P. Allison£©ºÍÈÕ±¾ÃâÒßѧ¼Ò±¾ÊüÓÓ£¨Tasuku Honjo£©, ÒÔÔÞÃÀËûÃÇÓйء°ÒÖÔ츺ÏòÃâÒßµ÷½ÚÓÃÓÚÖ×ÁöÒ½ÖΡ±µÄÔ´´·¢ÏÖ¡£»ã±¨½«½éÉÜ»ùÓÚÈËÌåÃâÒßϵͳҽÖÎÖ×ÁöµÄÁÆ·¨µÄ×êÑк¹Ç࣬°¬Àûɺͱ¾ÊüÓÓÔÚÍÆ¶¯ÃâÒßÁÆ·¨·½ÃæµÄÍ»ÆÆÐÔ¹¤×÷£¬ÒÔ¼°¶àÖÖ¿¹PD-1¼°ÆäÅäÌåµ°°×PD-L1µÄµ¥¿Ë¡¿¹ÌåµÄÁÙ´²ÀûÓÃÇé¿ö¡£
»ã±¨È˼ò½é£ºÀî±ó£¬²©Ê¿£¬¶þ¼¶×êÑÐÔ±£¬ÉϺ£ÊÐÃâÒßѧ×êÑÐËù¿ÎÌâ×鳤¡¢Óà?ѧÕß¡¢ÉϺ£½»´óÌØÆ¸½ÌÊÚ¡£Àî±ó²©Ê¿³Ö¾Ã´ÓÊÂÃâÒßµ÷½Ú¼°³Á´óÃâÒßÓйؼ²²¡Èç×ÔÉíÃâÒß²¡¡¢¹ýÃôÐÔ¼²²¡¼°¶ñÐÔÖ×ÁöÓйػù´¡¼°ÁÙ´²ÀûÓÃ×êÑС£½üÎåÄêÖ÷³Ö¹ú¶È»ù½ðίÃâÒßѧ½ÜÇà¡¢³Áµã¡¢Ãæ¸ßµÈ»ù½ð¡£½üÎåÄêÀî±ó¿ÎÌâ×éÔÚ¹ú¼ÊѧÊõ¿¯ÎïImmunity, PNAS, Nat Commun., JBC, J Immunol cutting edge, PLOS Pathogens, JCEM, Front Immunol, Br J Pharmacol.µÈ°ä·¢Í¨Ñ¶¼°¹²Í¬Í¨Ñ¶ÂÛÎÄ40ÓàÆª, ÔÚBlood, Science Immunology, PNAS, Nat Commun, J Exp Med£¬Cell ResµÈ°ä·¢ºÏ×÷ÂÛÎÄ10ÓàÆª£¬ÊÜÑûSpringer PressÖ÷±àÃâÒß´úлÓëÖ×ÁöÓ¢ÎÄÊé¼®1²¿, ÖÂÁ¦ÓÚ×êÑе÷½ÚÐÔTϸ°û²»±äÐԵĶ¯Ì¬µ÷¿Ø¼°ÆäÁÙ´²ÀûÓá£